Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access
NCT04489849
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Hemodialysis Access Failure
Interventions
DRUG:
Apixaban 2.5 MG
OTHER:
Active Control
Sponsor
National Taiwan University Hospital Hsin-Chu Branch